Overview

A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
A Study to assess, against a reference selumetinib capsule, if the drug levels of a variant of selumetinib capsule are comparable, and to assess how drug levels differed in another variant of Selumetinib in Healthy Male Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca